Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1972 2
1981 2
1984 3
1988 4
1990 11
1991 3
1992 4
1993 3
1994 16
1995 14
1996 14
1997 17
1998 16
1999 15
2000 31
2001 29
2002 32
2003 34
2004 47
2005 52
2006 56
2007 56
2008 107
2009 100
2010 130
2011 132
2012 166
2013 204
2014 195
2015 238
2016 263
2017 293
2018 327
2019 323
2020 415
2021 450
2022 551
2023 483
2024 257

Text availability

Article attribute

Article type

Publication date

Search Results

4,486 results

Results by year

Filters applied: . Clear all
Page 1
Sphingolipid metabolism controls mammalian heart regeneration.
Ji X, Chen Z, Wang Q, Li B, Wei Y, Li Y, Lin J, Cheng W, Guo Y, Wu S, Mao L, Xiang Y, Lan T, Gu S, Wei M, Zhang JZ, Jiang L, Wang J, Xu J, Cao N. Ji X, et al. Among authors: mao l. Cell Metab. 2024 Apr 2;36(4):839-856.e8. doi: 10.1016/j.cmet.2024.01.017. Epub 2024 Feb 16. Cell Metab. 2024. PMID: 38367623
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.
Xie X, Zhang W, Xiao M, Wei T, Qiu Y, Qiu J, Wang H, Qiu Z, Zhang S, Pan Y, Mao L, Li Y, Guo B, Yang W, Hu Y, Hu S, Gong Y, Yang J, Xiao G, Zhang Y, Bai X. Xie X, et al. Among authors: mao l. Blood. 2023 Jun 29;141(26):3184-3198. doi: 10.1182/blood.2022018619. Blood. 2023. PMID: 37001042 Free PMC article.
ANGPTL4 binds to the leptin receptor to regulate ectopic bone formation.
Hu H, Luo S, Lai P, Lai M, Mao L, Zhang S, Jiang Y, Wen J, Zhou W, Liu X, Wang L, Huang M, Hu Y, Zhao X, Xia L, Zhou W, Jiang Y, Zou Z, Liu A, Guo B, Bai X. Hu H, et al. Among authors: mao l. Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2310685120. doi: 10.1073/pnas.2310685120. Epub 2023 Dec 26. Proc Natl Acad Sci U S A. 2024. PMID: 38147550
Challenges of Anti-Mesothelin CAR-T-Cell Therapy.
Zhai X, Mao L, Wu M, Liu J, Yu S. Zhai X, et al. Among authors: mao l. Cancers (Basel). 2023 Feb 21;15(5):1357. doi: 10.3390/cancers15051357. Cancers (Basel). 2023. PMID: 36900151 Free PMC article. Review.
Biased regulation of glucocorticoid receptors signaling.
Mao L, Wei W, Chen J. Mao L, et al. Biomed Pharmacother. 2023 Sep;165:115145. doi: 10.1016/j.biopha.2023.115145. Epub 2023 Jul 14. Biomed Pharmacother. 2023. PMID: 37454592 Free article. Review.
Sensing at the single atom.
Mao L. Mao L. ACS Sens. 2024 Apr 26;9(4):1620-1621. doi: 10.1021/acssensors.4c00733. ACS Sens. 2024. PMID: 38666312 No abstract available.
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Mao L, Lian B, Li C, Bai X, Zhou L, Cui C, Chi Z, Sheng X, Wang X, Tang B, Yan X, Li S, Kong Y, Dai J, Wei X, Li J, Duan R, Xu H, Wu X, Yang Y, Cheng F, Zhang C, Xia F, Pang Z, Guo J, Si L. Mao L, et al. JAMA Oncol. 2023 Aug 1;9(8):1099-1107. doi: 10.1001/jamaoncol.2023.1363. JAMA Oncol. 2023. PMID: 37261804 Clinical Trial.
4,486 results